RYTM

Rhythm Pharmaceuticals Inc
28.095
-1.44 (-4.86%)
Upgrade to Real-Time
Regular Market
28.095
Volume 171,111
Bid Price 28.07
Ask Price 28.12
News (1)
Day High 29.825

Low
3.04

52 Week Range

High
34.99

Day Low 27.87
Company Name Stock Ticker Symbol Market Type
Rhythm Pharmaceuticals Inc RYTM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.44 -4.86% 28.095 15:44:11
Open Price Low Price High Price Close Price Prev Close
29.32 27.87 29.825 29.53
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,541 171,111 $ 28.75 $ 4,919,902 - 3.04 - 34.99
Last Trade Time Type Quantity Stock Price Currency
15:44:46 10 $ 28.10 USD

Period:

Draw Mode:

Rhythm Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.58B 56.35M 39.96M $ 3.15M $ - -1.36 -8.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -2.50k 1.70%

more financials information »

Rhythm Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical RYTM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week27.4129.9926.4028.70450,6000.6852.5%
1 Month32.0032.3026.3929.62574,386-3.91-12.2%
3 Months26.2834.9922.576828.57575,0851.826.91%
6 Months21.9434.9919.770425.25886,9296.1628.05%
1 Year6.9134.993.0415.101,173,66921.19306.58%
3 Years17.9443.263.0417.08607,97810.1656.61%
5 Years29.041943.263.0418.49439,131-0.9469-3.26%

Rhythm Pharmaceuticals Description

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies.